Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (IND#122782, NSC#683864) Added to High Risk Stratum Treatment
This phase III trial is studying the side effects of giving doxorubicin hydrochloride
together with combination chemotherapy and to compare different chemotherapy regimens to see
how well they work in treating young patients with newly diagnosed liver cancer. Drugs used
in chemotherapy work in different ways to stop the growth of tumor cells, either by killing
the cells or by stopping them from dividing. Giving more than one drug (combination
chemotherapy) may kill more tumor cells. It is not yet known whether surgery is more
effective with or without chemotherapy or which chemotherapy regimen may be more effective
in treating young patients with liver cancer.
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.